Added to YB: 2021-03-08
Pitch date: 2021-03-08
ANVS:US [bullish]
Annovis Bio, Inc.
-84.7%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration.
Market Cap
$56.0M
Pitch Price
$27.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.74
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Annovis Bio Inc ANVS:US
A summary for this pitch has not been created yet.
Read full article (0 min)